Hydrogen Europe Appoints New Board Members to Accelerate Deployment of Hydrogen Technologies in Europe
DRESDEN, Germany, 2016-07-01 09:00 CEST (GLOBE NEWSWIRE) --
FuelCell Energy Solutions, GmbH (FCES), a provider of ultra-clean, efficient and reliable stationary fuel cell power plants, announced the appointment of Andreas Froemmel, Vice President of Business and Commercial Development at FCES, to Vice-Chair of Hydrogen Europe (formerly New Energy World - Industry Group or NEW-IG); a leading industry association comprised of about 100 companies dedicated to advancing the deployment of hydrogen and fuel cell technologies in Europe. As Vice-Chair, Froemmel will work closely with newly appointed Board Chairman Raphaël Schoentgen of ENGIE, the French multinational utility company, to craft and execute the Hydrogen Europe initiatives.
“The Hydrogen Europe association is dedicated to developing awareness, markets, policy and regulatory framework to enable hydrogen deployment in Europe,” said newly appointed Vice-Chair Andreas Froemmel. “It represents the collaborative effort between industry, utilities and government to advance the integration of the hydrogen society.”
“Industry leaders working cooperatively and closely with regulatory and government officials, such as Hydrogen Europe is doing, illustrates the value of public/private partnerships for showcasing the many advantages of greater hydrogen adoption for clean and affordable power and transportation,” said Chip Bottone, President and Chief Executive Officer FuelCell Energy, Inc. and Managing Director, FuelCell Energy Solutions, GmbH. “The FuelCell Energy Solutions team is pleased to be part of the solution for achieving the energy and environmental goals of Europe.”
The Hydrogen Europe Board of Directors is comprised of executives from leading European companies including Dr. Katharina Beumelburg, Executive Vice-President Hydrogen Solutions, Siemens; Didier Pfleger, Senior Vice President, Alstom; Valérie Bouillon-Delporte, New Business Opportunities Director, Michelin; and Thomas Melczer, Director of Business Development, Proton Motor.
Hydrogen Europe’s mission is to enhance environmental and economic sustainability while positioning Europe at the forefront of global energy-related technological developments. It is the industry partner of the European Commission and the Research community (N.ERGHY) within the Fuel Cells and Hydrogen Joint Undertaking (FCH JU); this unique public-private partnership with N.ERGHY within the FCH JU supports Europe’s development and commercial introduction of clean technologies in the transport and energy sectors.
Mr. Froemmel’s leadership at FCES, since the company’s founding in 2012, has directly impacted the market awareness of affordable and ultra-clean stationary fuel cell power plants in Europe; implementing installations in Berlin with the German Government and in London, including a downtown office tower, 20 Fenchurch, and the Crown Estate owned Regent Street development as well as the execution of a project development agreement with EON Connecting Energies. Mr. Froemmel actively engages with European and German legislative and regulatory officials to advocate the whole fuel cell and hydrogen sector with a special focus on stationary fuel cell power plants at the confluence of energy, environmental and economic policies.
About Hydrogen Europe
Hydrogen Europe (formerly known as NEW-IG) is the leading industry association working to make hydrogen energy an everyday reality in Europe. The group represents almost 100 companies, both large and SMEs, and partners with the European Commission and the research community in a public-private partnership, Fuel Cells and Hydrogen Joint Undertaking, worth €1.3 billion to accelerate the market introduction of these clean technologies in energy and transport. It also serves as the industry’s reference point and key advocate towards European decision-makers. Learn more about Hydrogen Europe at http://hydrogeneurope.eu/
About FuelCell Energy Solutions, GmbH
FuelCell Energy Solutions manufactures, sells, installs, and services stationary fuel cell power plants that efficiently and economically generate electricity and usable high quality heat suitable for making steam. Administrative offices are located in Dresden, Germany and manufacturing operations are located in Taufkirchen, Germany. Continuous power generated at the point of use with the virtual absence of pollutants supports energy security and power reliability as well as sustainability initiatives. Ultra-Clean baseload distributed generation is attractive to electric utilities, universities, hospitals, government facilities, industrial operations and other locations with significant power needs. For more information please visit www.fces.de.
Direct FuelCell, DFC, DFC/T, DFC-H2, DFC-ERG and FuelCell Energy logo are all registered trademarks in the U.S.A. of FuelCell Energy, Inc.
FuelCell Energy Solutions GmbH
+ 49 351 2553 7397
FuelCell Energy, Inc.
Vice President Investor Relations
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL(TM) Test for Hodgkin's Lymphoma20.2.2018 14:00 | Pressemelding
3D Signatures Inc. / 3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL(TM) Test for Hodgkin's Lymphoma . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. TORONTO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HLTM, 3DS' test in development for Hodgkin's lymphoma (HL), shows that the Company's TeloViewTM platform is able to distinguish, with a high degree of statistical significance, multiple differences between a patient group that responds to standard ABVD chemotherapy, and a group that relapses or is refractory to treatment within the first 12 months. Telo-HLTM is intended to provide clinicians with the first biomarker to identify the 15% - 20% of new HL patients who will likely fail standard chemot
Cisco Leadership In Automation Continues With New Network Automation Portfolio for Service Providers20.2.2018 14:00 | Pressemelding
Company launches industry's most comprehensive closed-loop multi-vendor, multi-domain automation solution SAN JOSE, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Cisco today introduced its new Cisco Crosswork Network Automation software portfolio to improve how global service providers run their large-scale networks. The solutions are designed to work together to offer greater network visibility at scale (mass awareness), data-driven insights (augmented intelligence) and outcome-based automation (proactive control). With 27 billion devices and connections1 expected to be running on service provider networks by 2021, the pressure is on for industry adoption of complete lifecycle network automation and intent-based networking to help networks predict change and react in near real time. Traditional operations staff will not be able to keep up with adding nearly 10 percent more devices every year without changing how they work. When Cisco automation is utilized, typical results include a 70 pe
Crown Bioscience Inc.: CAR T-Cell Therapy Platform20.2.2018 14:00 | Pressemelding
Bioluminescent Imaging Capabilities Accelerate Robust CAR T-Cell Therapy SAN DIEGO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, enhances its existing platform for chimeric antigen receptor (CAR) T-cell agent evaluation with bioluminescent imaging capabilities. CAR T-cell therapies are an exciting advent in the evolving field of immune-therapeutics. CAR T-cell agents utilize CAR T-cells that recognize tumor-associated antigens and subsequently promote tumor elimination. The remarkable efficacy of CAR T-cell compounds has led to hundreds of clinical trials with two notable successes recently approved by the FDA to treat refractory B-cell precursor acute lymphoblastic leukemia (ALL). CrownBio, a leader in the field of preclinical immuno
Standard Lithium Provides California Lithium Exploration Update20.2.2018 11:30 | Pressemelding
VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSX-V:SLL) (OTCQX:STLHF) (FRA:S5L) is pleased to provide an update of the exploration program that is in full swing at the Company's California Lithium Properties. The Company and their drilling contractors have now completed six exploration boreholes across the Bristol Dry Lake Project area, and three of the exploration holes have had temporary sampling casing installed so that high quality lithium brine samples can be collected from the extensive lithium brine-bearing aquifers. The temporary PVC casing also allows for down-hole geophysics to be completed to collect additional geological and hydrogeological data. Drilling of an observation well is currently ongoing, and once completed, will allow for robust pumping tests to be performed at the Project. An additional exploration well and observation well are already permitted, and the Company is awaiting final con
Infomedia goes global with acquisition of Opoint Technology20.2.2018 10:11 | Pressemelding
COPENHAGEN, Denmark, Feb. 20, 2018 (GLOBE NEWSWIRE) -- The Copenhagen based, Nordic media intelligence company, Infomedia acquires Norwegian Opoint Technology from M-brain. The transfer includes Opoint's leading global web-crawling technology for online media, the business of web-crawling services for +70 international media monitors and key personnel in Oslo and Chennai. Continued international growth in insights, global content and social media Over the last couple of years, Infomedia had begun a journey towards becoming a Nordic player. The company invested heavily in new technology, data science, insight products and services and new partnerships. "We transformed Infomedia from a 'traditional' media monitor to becoming a full-scale media intelligence company with strong insights capabilities and leading solutions within all aspects of the media space, including print, online, broadcast and social media," says Infomedia's CEO, Thomas Vejlemand. He continues; "The acquisition marks y
SoftServe and Adjoint Deliver the Future of Blockchain in FinTech20.2.2018 07:00 | Pressemelding
New Partnership to Bring Financial Sector Unmatched Security and Scalability for Mission Critical Blockchain Applications LONDON, Feb. 20, 2018 (GLOBE NEWSWIRE) -- SoftServe, a leading digital consulting company, today announced its partnership with Adjoint, a developer of distributed ledger technology to accelerate automation through smart contracts and improve transactional privacy and security through blockchain in the financial and commodities industries. Adjoint's Uplink is an open source platform designed to enable enterprises in the financial sector, from banking and capital markets, to insurance, asset management, and commodities trading; to quickly deploy, maintain, verify and execute smart contracts globally on a private, permissioned distributed ledger. SoftServe will work with Adjoint to specifically help customers assimilate and on-board the Uplink platform effectively. SoftServe will tap into its deep technical expertise in blockchain, user experience and design, and go-t
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom